Results 281 to 290 of about 432,621 (360)
CDK11 inhibition stabilises the tumour suppressor p53 and triggers the production of an alternative p21WAF1 splice variant p21L, through the inactivation of the spliceosomal protein SF3B1. Unlike the canonical p21WAF1 protein, p21L is localised in the cytoplasm and has reduced cell cycle‐blocking activity.
Radovan Krejcir +12 more
wiley +1 more source
COPD – the story of 2 GPs, 5 pharmacists, 3 physios and an exercise physiologist
Bridget Kirby
openalex +1 more source
A mouse model for vascular normalization and a human breast cancer cohort were studied to understand the relationship between vascular leakage and tumor immune suppression. For this, endothelial and immune cell RNAseq, staining for vascular function, and immune cell profiling were employed.
Liqun He +8 more
wiley +1 more source
Knowledge, attitudes, and practices of community pharmacists on pharmacological approaches to smoking cessation in Saudi Arabia. [PDF]
Alshehri FS.
europepmc +1 more source
Liquid biopsy epigenetics: establishing a molecular profile based on cell‐free DNA
Cell‐free DNA (cfDNA) fragments in plasma from cancer patients carry epigenetic signatures reflecting their cells of origin. These epigenetic features include DNA methylation, nucleosome modifications, and variations in fragmentation. This review describes the biological properties of each feature and explores optimal strategies for harnessing cfDNA ...
Christoffer Trier Maansson +2 more
wiley +1 more source
Introduction of methicillin-resistant <i>Staphylococcus aureus</i> (MRSA) nasal polymerase chain reaction testing combined with pharmacist ordering and intervention reduces anti-MRSA antibiotic use in a multi-hospital system. [PDF]
Collins CD +4 more
europepmc +1 more source
Intein‐based modular chimeric antigen receptor platform for specific CD19/CD20 co‐targeting
CARtein is a modular CAR platform that uses split inteins to splice antigen‐recognition modules onto a universal signaling backbone, enabling precise, scarless assembly without re‐engineering signaling domains. Deployed here against CD19 and CD20 in B‐cell malignancies, the design supports flexible multi‐antigen targeting to boost T‐cell activation and
Pablo Gonzalez‐Garcia +9 more
wiley +1 more source
How do pharmacists navigate clinical uncertainty when reviewing polypharmacy? A critical literature review. [PDF]
Kallis TJ, Mattick K, Scott J, Payne RA.
europepmc +1 more source

